SCHEMBL13097077

SCHEMBL13097077

Cc1cc(-n2cc(Cl)cn2)cc(C)c1-c1c(O)sc(-c2ccccc2)nc1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.38
ALDH1A1 P00352 5/20 0.38
MAPT P10636 4/20 0.38
HPGD P15428 3/20 0.38
STAT6 P42226 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
KDM4E B2RXH2 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
HSD17B10 Q99714 2/20 0.36
JAK2 O60674 1/20 0.36
GAA P10253 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
ALOX12 P18054 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL812067 0.78 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1MAPTHPGDNPSR1
SCHEMBL7804643 0.78 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1MAPTHPGDNPSR1
SCHEMBL13527170 0.77 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1MAPTHPGDNPSR1
SCHEMBL9883892 0.75 TRPM8 (0.46) SMN1; SMN2ALDH1A1MAPTHPGDL3MBTL1
SCHEMBL10309270 0.72 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1MAPTHPGDNPSR1
SCHEMBL15450056 0.71 CDC7 (0.45) SMN1; SMN2ALDH1A1MAPTL3MBTL1KMT2A
SCHEMBL14432142 0.71 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1MAPTHPGDNPSR1
SCHEMBL13097099 0.71 MAPT (0.38) SMN1; SMN2ALDH1A1MAPTHPGDSTAT6
SCHEMBL12270067 0.70 MEN1 (0.39) ALDH1A1MAPTL3MBTL1KMT2AMEN1
SCHEMBL16153979 0.68 NR1H3 (0.58) SMN1; SMN2ALDH1A1MAPTHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267964-A1 N-HETEROCYCLYLPHENYL-SUBSTITUTED CYCLIC KETOENOLS FISCHER REINER 2010-10-21 US disclosed
US-20100267964-A1 N-HETEROCYCLYLPHENYL-SUBSTITUTED CYCLIC KETOENOLS FISCHER REINER 2010-10-21 US disclosed
US-7776791-B2 N-heterocyclyl phenyl-substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2010-08-17 US disclosed
US-7776791-B2 N-heterocyclyl phenyl-substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2010-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267964-A1 N-HETEROCYCLYLPHENYL-SUBSTITUTED CYCLIC KETOENOLS CYP17A1, CCNY, CCNE2 SMN1; SMN2 4379/4885ALDH1A1 2486/4885MAPT 4552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.